Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006444 · ClinicalTrials.gov registry record
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
A clinical trial of HIV Infections and Papilloma, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 160
- Enrollment target
- 20
- Study locations
NCT00006444 is a study of HIV Infections and Papilloma that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 160 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (64% lower). The trial reports 20 study locations across 8 states.
The verdict
NCT00006444, a study of HIV Infections and Papilloma, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to see how often human papillomavirus (HPV) occurs in HIV-infected women who have not taken anti-HIV drugs and to learn whether taking anti-HIV drugs will affect HPV in women. HIV infection increases the risk of getting HPV infection. Findings suggest that HIV infection as well as a weakened immune system may increase the chances of getting HPV. Aggressive anti-HIV medication has been shown to strengthen the immune system. Researchers want to learn whether anti-HIV drugs affect the HPV virus or decrease the chances of getting HPV. This study is important because it may provide important information to help manage a woman's health and to determine a woman's risk for developing problems with the cervix (outer end of the uterus).
Conditions Studied
Study Locations (20)
California
- Children's Hosp of Los Angeles/UCLA Med Ctr - Los Angeles
- Univ of Southern California / LA County USC Med Ctr - Los Angeles
- Los Angeles County - USC Med Ctr - Los Angeles
- UCLA CARE Ctr - Los Angeles
- Univ of California, San Diego - San Diego
- University of California San Francisco - San Francisco
- San Mateo County AIDS Program - Stanford
- Stanford Univ - Stanford
- Willow Clinic - Stanford
Florida
- North Broward Hosp District - Fort Lauderdale
- Univ of Florida Health Science Ctr / Pediatrics - Jacksonville
- Univ of Miami School of Medicine - Miami
- Univ of Miami / Jackson Memorial Hosp - Miami
- Univ of Miami (Pediatric) - Miami
Alabama
- Univ of Alabama at Birmingham - Birmingham
Colorado
- Univ of Colorado Health Sciences Ctr, Denver - Denver
District of Columbia
- Howard Univ Hosp - Washington D.C.
Georgia
- Emory Univ - Atlanta
Hawaii
- Univ of Hawaii - Honolulu
Illinois
- Mt Sinai Hosp Med Ctr / Dept of Pediatrics - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2000-11 |
| Est. Completion | 2005-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006444
The ClinicalTrials.gov registry entry for NCT00006444 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (64% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00006444 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT00006444 about?
NCT00006444 is a clinical study titled "The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women". The purpose of this study is to see how often human papillomavirus (HPV) occurs in HIV-infected women who have not taken anti-HIV drugs and to learn whether taking anti-HIV drugs will affect HPV in women. HIV infection increases the risk of getting HPV infection. Findings suggest that HIV infection...
What is the current status of trial NCT00006444?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2000-11. Estimated completion is 2005-08.
What conditions does trial NCT00006444 study?
This clinical trial studies the following conditions: HIV Infections, Papilloma.
Who is sponsoring clinical trial NCT00006444?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00006444 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.